Suppr超能文献

基于与肝纤维化评分的一致性分析预测结直肠癌肝转移及复发情况

Prediction of hepatic metastasis and relapse in colorectal cancers based on concordance analyses with liver fibrosis scores.

作者信息

Hu Xiang, Marietta Audrey, Dai Wei-Xing, Li Ya-Qi, Ma Xiao-Ji, Zhang Long, Cai San-Jun, Peng Jun-Jie

机构信息

Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 20032, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

出版信息

Clin Transl Med. 2020 Feb 5;9(1):13. doi: 10.1186/s40169-020-0264-3.

Abstract

BACKGROUND

Liver fibrosis, resulted from several liver diseases, are increasing up to 25% in population in global. It remains undetermined how much impact liver fibrosis have on the development of hepatic metastasis and relapse in colorectal cancer (CRC). Hence the aim of this study was to clarify the role of liver fibrosis on hepatic metastasis and relapse in CRC undergoing curative therapy.

METHODS

We enrolled consecutive 1652 patients with radical colorectal surgery as the discovery cohort, and the validation set enrolled 432 CRC patients with hepatic metastasis. To determine liver fibrosis, the NFS, FIB4 and APRI scores were applied. The influence of liver fibrosis on hepatic metastasis and relapse was assessed by survival analyses. Nomograms with fibrosis score incorporated were established to identify the incremental value for individualized relapse estimation, which was then assessed with respect to calibration, discrimination, and clinical usefulness.

RESULTS

The high liver fibrosis score patients had significantly worse outcomes than low score in 5-year hepatic metastasis (22.6 vs. 8.7%) in discovery cohort, and relapse (58.2 vs. 44.1%) in validation cohort. Multivariate analysis also revealed liver fibrosis as an independent prognostic factor. The distribution analysis also demonstrated higher liver fibrosis score a powerful prognostic factor for hepatic metastasis and relapse. The nomogram incorporated with liver fibrosis score resulted in better performance than TNM staging system and clinicopathologic nomograms. Importantly, the discriminatory capacity of the fibrosis score was superior to that of the CRS score in predicting hepatic specific disease-free survival (DFS) and relapse-free survival (RFS), as demonstrated by the C-index and AUC. The concordance study showed well agreement among NFS, FIB4 and APRI in predicting DFS and RFS. Among these three noninvasive liver fibrosis scores, NFS score performed the best in predicting hepatic specific DFS and RFS.

CONCLUSION

The liver fibrosis was a powerful predictor of hepatic specific DFS and RFS in CRC. Fibrosis niche may be a favorable microenvironment for metastatic formation in the liver.

摘要

背景

由多种肝脏疾病引起的肝纤维化在全球人口中的发病率正上升至25%。肝纤维化对结直肠癌(CRC)肝转移和复发的发展有多大影响仍未确定。因此,本研究的目的是阐明肝纤维化在接受根治性治疗的CRC肝转移和复发中的作用。

方法

我们纳入了连续1652例接受根治性结直肠手术的患者作为发现队列,验证集纳入了432例有肝转移的CRC患者。为了确定肝纤维化,应用了NFS、FIB4和APRI评分。通过生存分析评估肝纤维化对肝转移和复发的影响。建立了纳入纤维化评分的列线图,以确定个体复发估计的增加值,然后对其校准、区分度和临床实用性进行评估。

结果

在发现队列中,高肝纤维化评分患者的5年肝转移情况(22.6%对8.7%)和验证队列中的复发情况(58.2%对44.1%)明显比低评分患者差。多变量分析还显示肝纤维化是一个独立的预后因素。分布分析也表明较高的肝纤维化评分是肝转移和复发的有力预后因素。纳入肝纤维化评分的列线图比TNM分期系统和临床病理列线图表现更好。重要的是,如C指数和AUC所示,在预测肝脏特异性无病生存期(DFS)和无复发生存期(RFS)方面,纤维化评分的区分能力优于CRS评分。一致性研究表明,NFS、FIB4和APRI在预测DFS和RFS方面具有良好的一致性。在这三个非侵入性肝纤维化评分中,NFS评分在预测肝脏特异性DFS和RFS方面表现最佳。

结论

肝纤维化是CRC肝脏特异性DFS和RFS的有力预测指标。纤维化微环境可能是肝脏转移形成的有利微环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e29/7002812/aa408c77b32c/40169_2020_264_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验